Highly mutagenic exocyclic DNA adducts are substrates for the human nucleotide incision repair pathway

PLoS One. 2012;7(12):e51776. doi: 10.1371/journal.pone.0051776. Epub 2012 Dec 14.

Abstract

Background: Oxygen free radicals induce lipid peroxidation (LPO) that damages and breaks polyunsaturated fatty acids in cell membranes. LPO-derived aldehydes and hydroxyalkenals react with DNA leading to the formation of etheno(ε)-bases including 1,N(6)-ethenoadenine (εA) and 3,N(4)-ethenocytosine (εC). The εA and εC residues are highly mutagenic in mammalian cells and eliminated in the base excision repair (BER) pathway and/or by AlkB family proteins in the direct damage reversal process. BER initiated by DNA glycosylases is thought to be the major pathway for the removal of non-bulky endogenous base damage. Alternatively, in the nucleotide incision repair (NIR) pathway, the apurinic/apyrimidinic (AP) endonucleases can directly incise DNA duplex 5' to a damaged base in a DNA glycosylase-independent manner.

Methodology/principal findings: Here we have characterized the substrate specificity of human major AP endonuclease 1, APE1, towards εA, εC, thymine glycol (Tg) and 7,8-dihydro-8-oxoguanine (8oxoG) residues when present in duplex DNA. APE1 cleaves oligonucleotide duplexes containing εA, εC and Tg, but not those containing 8oxoG. Activity depends strongly on sequence context. The apparent kinetic parameters of the reactions suggest that APE1 has a high affinity for DNA containing ε-bases but cleaves DNA duplexes at an extremely slow rate. Consistent with this observation, oligonucleotide duplexes containing an ε-base strongly inhibit AP site nicking activity of APE1 with IC(50) values in the range of 5-10 nM. MALDI-TOF MS analysis of the reaction products demonstrated that APE1-catalyzed cleavage of εA•T and εC•G duplexes generates, as expected, DNA fragments containing 5'-terminal ε-base residue.

Conclusions/significance: The fact that ε-bases and Tg in duplex DNA are recognized and cleaved by APE1 in vitro, suggests that NIR may act as a backup pathway to BER to remove a large variety of genotoxic base lesions in human cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / metabolism
  • Biocatalysis
  • Cell Extracts
  • Cell-Free System
  • Cytosine / analogs & derivatives
  • Cytosine / metabolism
  • DNA Adducts / chemistry
  • DNA Adducts / metabolism*
  • DNA Glycosylases / metabolism
  • DNA Repair*
  • DNA-(Apurinic or Apyrimidinic Site) Lyase / metabolism
  • HeLa Cells
  • Humans
  • Kinetics
  • Mutagens / metabolism*
  • Oligonucleotides / metabolism
  • Oxidation-Reduction
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Substrate Specificity
  • Thymine / analogs & derivatives
  • Thymine / metabolism
  • Time Factors

Substances

  • 3,N(4)-ethenocytosine
  • Cell Extracts
  • DNA Adducts
  • Mutagens
  • Oligonucleotides
  • 1,N(6)-ethenoadenine
  • thymine glycol
  • Cytosine
  • DNA Glycosylases
  • APEX1 protein, human
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
  • Adenine
  • Thymine

Grants and funding

This work was supported by Polish-French collaborative grants N°346/N-INCA/2008/0 and N°303 819540 [to BT] and grants from Fondation pour la Recherche Médicale (http://www.frm.org) [EQUIPES FRM 2007 to MS]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS N5479-Russie, and CNRS-INCA-MSHE Franco-Pologne #3037987 to MS]; Electricité de France (http://www.edf.fr) Contrat Radioprotection [RB 2011 to MS and DG]; Fondation de France (http://www.fondationdefrance.org) [#2012 00029161 to AAI]. Russian Ministry of Education and Science (http://mon.gov.ru) [to OSF and AAI]. PP was supported by the fellowship from International PhD Projects Programme of Foundation for Polish Science: “Studies of nucleic acids and proteins - from basic to applied research”. The project is co-financed by European Union - Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.